Kane Biotech Inc.
Kane Biotech Inc. (KNE.V) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KNE.V · as of Jun 8, 2026
Key Statistics
Explore Kane Biotech Inc. Data
kne.v stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
kne.v competitorsKNE.V
APLI.TO
APS.TO
AVCR.V
CANB.V
HEAL.CNStock Performance
Full HistoryAbout Kane Biotech Inc.
Kane Biotech Inc. a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internatio…
what is kane biotech inc. · kne.v stock overview · kane biotech inc. company profile · who is kane biotech inc. ceo · kne.v TSXV · kane biotech inc. headquarters · kane biotech inc. business segments
About Stock Overview & Key Data
Kane Biotech Inc. (KNE.V) is a Healthcare company in the Biotechnology industry, listed on TSXV since Oct 1, 2003. As of the latest trading session, KNE.V stock price is $0.04, with a market capitalization of $6.4M. The stock has returned -41.67% over the past 12 months and -12.50% year-to-date.
In fiscal year 2025, Kane Biotech Inc. reported revenue of $427869.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Kane Biotech Inc. (KNE.V) stock price is $0.04. The stock is traded on TSXV under the ticker symbol KNE.V. The 52-week range is $0.03 – $0.07.